Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements
Sabelli HC; Fawcett J; Gusovsky F; Javaid JI;
Wynn P; Edwards J; Jeffriess H; Kravitz H
J Clin Psychiatry 1986 Feb; 47(2):66-70


To test the hypothesis that 2-phenylethylamine (PEA) modulates affect, plasma levels and urinary excretion of its main metabolite, phenylacetic acid (PAA), were studied in depressed and manic subjects, and the mood-elevating effects of its precursor, L-phenylalanine, were studied in depressed subjects. Mean total plasma PAA concentrations were 491.83 +/- 232.84 ng/ml in 12 healthy volunteers and 300.33 +/- 197.44 ng/ml in 23 drug-free patients with major depression. The 24-hour urinary PAA excretion was also measured in 48 healthy volunteers (141.1 +/- 10.2 mg PAA/24 hr) and in 144 patients with major depression (78.2 +/- 41.0 mg PAA/24 hr). The results suggest that low plasma and urinary PAA may be state markers for depression and are compatible with the PEA hypothesis. In further support, phenylalanine elevated mood in 31 of 40 depressives.

Brain imaging
The brain in love
PEA and exercise
Food of the gods?
Chocolate: history
PEA and dopamine
Stoned chocaholics?
PEA and antidepressants
Chocolate: food or drug?
PEA and antidepressants